US Stock MarketDetailed Quotes
CMMB Chemomab Therapeutics
- 0.700
- +0.000+0.03%
Trading Apr 19 10:18 ET
9.95MMarket Cap0.34P/E (TTM)
0.740High0.700Low4.20KVolume0.700Open0.700Pre Close2.97KTurnover0.05%Turnover Ratio0.34P/E (Static)14.20MShares1.89052wk High0.58P/B6.58MFloat Cap0.42052wk Low--Dividend TTM9.39MShs Float184.000Historical High--Div YieldTTM5.70%Amplitude0.420Historical Low0.705Avg Price1Lot Size
About Chemomab Therapeutics Company
Chemomab Therapeutics Ltd. operates as a clinical-stage biotech company. It discovers and develops therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.
Company Profile
SymbolCMMB
Company NameChemomab Therapeutics
Listing DateFeb 12, 2019
Issue Price11.50
Founded2011
CEODr. Adi Mor, PhD
MarketNASDAQ
Employees20
Securities TypeDR
ADS Ratio1.0 : 20.0
Fiscal Year Ends12-31
AddressKiryat Atidim,Building 7
CityTel Aviv
ProvinceTel Aviv
CountryIsrael
Zip Code6158002
Phone972-77-331-0156
Websitehttp://www.chemomab.com
Company Executives
- Name
- Position
- Salary
- Dr. Adi Mor, PhD
- Chief Executive Officer, Chief Scientific Officer and Director
- 435.40K
- Dr. Matthew B. Frankel
- Chief Medical Officer
- --
- Sigal Fattal
- Chief Financial Officer
- --
- Dr. Nissim Darvish, M.D.,PhD
- Chairman of the Board
- 123.00K
- Neil Cohen
- Independent Director
- 123.00K
- Jill M. Quigley, Esq.
- Independent Director
- 38.00K
- Dr. Claude Nicaise,M.D.
- Independent Director
- 123.00K
- Dr. Alan C. Moses, F.A.C.P.,M.D.
- Independent Director
- 119.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
